isolyte s ph 7.4

Generic: sodium chloride, sodium gluconate, sodium acetate, potassium chloride, magnesium chloride, sodium phosphate, dibasic, and potassium phosphate

Labeler: b. braun medical inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name isolyte s ph 7.4
Generic Name sodium chloride, sodium gluconate, sodium acetate, potassium chloride, magnesium chloride, sodium phosphate, dibasic, and potassium phosphate
Labeler b. braun medical inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

magnesium chloride .03 g/100mL, potassium chloride .037 g/100mL, potassium phosphate, monobasic .00082 g/100mL, sodium acetate .37 g/100mL, sodium chloride .53 g/100mL, sodium gluconate .5 g/100mL, sodium phosphate, dibasic .012 g/100mL

Manufacturer
B. Braun Medical Inc.

Identifiers & Regulatory

Product NDC 0264-7707
Product ID 0264-7707_88c0041b-2b08-4ca1-b733-60f8b5723892
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA019696
Listing Expiration 2026-12-31
Marketing Start 1989-09-29

Pharmacologic Class

Classes
calculi dissolution agent [epc] increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] inhibition small intestine fluid/electrolyte absorption [pe] magnesium ion exchange activity [moa] osmotic activity [moa] osmotic laxative [epc] potassium compounds [cs] potassium salt [epc] stimulation large intestine fluid/electrolyte secretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 02647707
Hyphenated Format 0264-7707

Supplemental Identifiers

RxCUI
800925 800928
UNII
02F3473H9O 660YQ98I10 4J9FJ0HL51 4550K0SC9B 451W47IQ8X R6Q3791S76 GR686LBA74

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name isolyte s ph 7.4 (source: ndc)
Generic Name sodium chloride, sodium gluconate, sodium acetate, potassium chloride, magnesium chloride, sodium phosphate, dibasic, and potassium phosphate (source: ndc)
Application Number NDA019696 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • .03 g/100mL
  • .037 g/100mL
  • .00082 g/100mL
  • .37 g/100mL
  • .53 g/100mL
  • .5 g/100mL
  • .012 g/100mL
source: ndc
Packaging
  • 12 CONTAINER in 1 CASE (0264-7707-00) / 1000 mL in 1 CONTAINER
  • 24 CONTAINER in 1 CASE (0264-7707-10) / 500 mL in 1 CONTAINER
source: ndc

Packages (2)

Ingredients (7)

magnesium chloride (.03 g/100mL) potassium chloride (.037 g/100mL) potassium phosphate, monobasic (.00082 g/100mL) sodium acetate (.37 g/100mL) sodium chloride (.53 g/100mL) sodium gluconate (.5 g/100mL) sodium phosphate, dibasic (.012 g/100mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "88c0041b-2b08-4ca1-b733-60f8b5723892", "openfda": {"unii": ["02F3473H9O", "660YQ98I10", "4J9FJ0HL51", "4550K0SC9B", "451W47IQ8X", "R6Q3791S76", "GR686LBA74"], "rxcui": ["800925", "800928"], "spl_set_id": ["150437b6-320e-4c69-a434-2a26a1f0b2e4"], "manufacturer_name": ["B. Braun Medical Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 CONTAINER in 1 CASE (0264-7707-00)  / 1000 mL in 1 CONTAINER", "package_ndc": "0264-7707-00", "marketing_start_date": "19890929"}, {"sample": false, "description": "24 CONTAINER in 1 CASE (0264-7707-10)  / 500 mL in 1 CONTAINER", "package_ndc": "0264-7707-10", "marketing_start_date": "19890929"}], "brand_name": "Isolyte S pH 7.4", "product_id": "0264-7707_88c0041b-2b08-4ca1-b733-60f8b5723892", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calculi Dissolution Agent [EPC]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "0264-7707", "generic_name": "SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, and POTASSIUM PHOSPHATE", "labeler_name": "B. Braun Medical Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Isolyte S pH 7.4", "active_ingredients": [{"name": "MAGNESIUM CHLORIDE", "strength": ".03 g/100mL"}, {"name": "POTASSIUM CHLORIDE", "strength": ".037 g/100mL"}, {"name": "POTASSIUM PHOSPHATE, MONOBASIC", "strength": ".00082 g/100mL"}, {"name": "SODIUM ACETATE", "strength": ".37 g/100mL"}, {"name": "SODIUM CHLORIDE", "strength": ".53 g/100mL"}, {"name": "SODIUM GLUCONATE", "strength": ".5 g/100mL"}, {"name": "SODIUM PHOSPHATE, DIBASIC", "strength": ".012 g/100mL"}], "application_number": "NDA019696", "marketing_category": "NDA", "marketing_start_date": "19890929", "listing_expiration_date": "20261231"}